This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
between 30 and 75
years old
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

This study will evaluate the effect of Helicobacter pylori eradication therapy on the healing of iatrogenic gastric ulcer caused by endoscopic mucosal resection of gastric neoplastic lesions and is a multicenter, randomized, double blind, and placebo controlled trial.

Provided treatments

  • Drug: Lansoprazole (proton pump inhibitor), amoxicillin, clarythromycin
  • Drug: Lansoprazole (proton pump inhibitor), placebo
Tris trial is registered with FDA with number: NCT00926809. The sponsor of the trial is Korean College of Helicobacter and Upper Gastrointestinal Research and it is looking for 232 volunteers for the current phase.
Official trial title:
Helicobacter Pylori Eradication Therapy on the Healing of Iatrogenic Gastric Ulcer After Endoscopic Mucosal Resection of Gastric Neoplastic Lesions: a Multicenter, Randomized, Double Blind, and Placebo Controlled Trial